73 related articles for article (PubMed ID: 3604838)
1. Circulating immune complexes in breast and lung cancer, before and after chemotherapy.
García MS; Barañao RI; Fernández O; Bordenave H; Rumi LS
Allergol Immunopathol (Madr); 1987; 15(1):15-8. PubMed ID: 3604838
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal follow-up circulating immune complexes of the serum in patients with breast cancer.
Nekulová M; Tomanová J; Lang BA
Neoplasma; 1982; 29(5):573-7. PubMed ID: 7177247
[TBL] [Abstract][Full Text] [Related]
3. Significance of breast carcinoma-associated antigens as a monitor of tumor burden: characterization by monoclonal antibodies.
Salinas FA; Wee KH; Ceriani RL
Cancer Res; 1987 Feb; 47(3):907-13. PubMed ID: 3802085
[TBL] [Abstract][Full Text] [Related]
4. [Circulating immune complexes in breast cancer].
Abecassis J; Petit JC; Eber M; Klein T; Rodier D; Janser JC; Methlin G
Bull Cancer; 1985; 72(1):42-7. PubMed ID: 3872691
[TBL] [Abstract][Full Text] [Related]
5. Immunocomplexes and primary lung cancer.
Lenzini L; Rottoli L; Sestini P; Carriero G; Sani G; Gotti G
Allergol Immunopathol (Madr); 1981; 9(2):119-22. PubMed ID: 6270995
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility and monitoring of breast cancer by circulating immune complexes.
Dass TK; Aziz M; Rattan A; Tyagi SP
Indian J Pathol Microbiol; 1992 Oct; 35(4):298-307. PubMed ID: 1344219
[TBL] [Abstract][Full Text] [Related]
7. [Effects of chemotherapy on circulating angiogenic factor levels in patients with breast cancer].
Tang JH; Zhao JH; Gong JP; Qin JW; Pan LQ; Xu ZY
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):210-4. PubMed ID: 17649639
[TBL] [Abstract][Full Text] [Related]
8. The fluctuation of circulating immune complexes level in patients with malignancy.
Vodvárka P; Vodvárka T; Foukalová J
Neoplasma; 1984; 31(4):485-9. PubMed ID: 6472521
[TBL] [Abstract][Full Text] [Related]
9. Circulating immune complexes (CIC) as tumor marker in the follow-up of breast cancer.
Neri B; Comparini T; Ciatto S; Cataliotti L; Distante V; Bartalucci S
Cancer Detect Prev; 1985; 8(1-2):53-6. PubMed ID: 4064052
[TBL] [Abstract][Full Text] [Related]
10. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
[TBL] [Abstract][Full Text] [Related]
11. Role of circulating immune complexes in prognostic evaluation and management of genitourinary cancer patients.
Aziz M; Das TK; Rattan A
Indian J Cancer; 1997 Sep; 34(3):111-20. PubMed ID: 9491672
[TBL] [Abstract][Full Text] [Related]
12. Thyroid function in women after multimodal treatment for breast cancer stage II/III: comparison with controls from a population sample.
Reinertsen KV; Cvancarova M; Wist E; Bjøro T; Dahl AA; Danielsen T; Fosså SD
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):764-70. PubMed ID: 19286332
[TBL] [Abstract][Full Text] [Related]
13. Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients.
Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1062-73. PubMed ID: 15234040
[TBL] [Abstract][Full Text] [Related]
14. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
[TBL] [Abstract][Full Text] [Related]
16. p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients.
Bottini A; Berruti A; Bersiga A; Brizzi MP; Brunelli A; Gorzegno G; DiMarco B; Aguggini S; Bolsi G; Cirillo F; Filippini L; Betri E; Bertoli G; Alquati P; Dogliotti L
Clin Cancer Res; 2000 Jul; 6(7):2751-8. PubMed ID: 10914720
[TBL] [Abstract][Full Text] [Related]
17. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
[TBL] [Abstract][Full Text] [Related]
18. High-dose chemotherapy in patients with breast cancer: evaluation of infusing peripheral blood stem cells containing occult tumor cells.
Weaver CH; Moss T; Schwartzberg LS; Zhen B; West J; Rhinehart S; Campos L; Beeker T; Lautersztain L; Messino M; Buckner CD
Bone Marrow Transplant; 1998 Jun; 21(11):1117-24. PubMed ID: 9645574
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of two different regimens as neoadjuvant chemotherapy for breast cancer].
Yang D; Tong F; Cao Y; Liu P; Zhou B; Liu H; Qiao X; Zhang J
Zhonghua Zhong Liu Za Zhi; 2002 May; 24(3):303-5. PubMed ID: 12515634
[TBL] [Abstract][Full Text] [Related]
20. Circulating immune complexes in advanced Hodgkin's disease: qualitative analysis and prognostic significance.
Tomasević Z; Jelić S
Arch Immunol Ther Exp (Warsz); 2000; 48(3):195-200. PubMed ID: 10912625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
